Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
Background: Diabetic nephropathy (DN) is one of the most common complications of diabetes and the primary cause of end-stage renal disease. At present, renin–angiotensin–aldosterone system (RAAS) blockers have been applied as first-class drugs to restrain development of DN; however, its long-term ef...
Main Authors: | Tingting Zhao, Minyi Li, Qian Xiang, Beifeng Lie, Deqi Chen, Weiming Wang, Xuling Li, Tiancheng Xu, Xi Zhang, Yuntong Li, Ruixue Dong, Xinwen Du, Yilin Wang, Junzheng Yang, Bao He, Quan Zhu, Tingting Duan, Zhenghai Li, Youhua Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.872940/full |
Similar Items
-
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways
by: Tingting Zhao, et al.
Published: (2023-03-01) -
Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones
by: Haizhao Liu, et al.
Published: (2023-02-01) -
Bufei Yishen Formula Inhibits the Cell Senescence in COPD by Up-Regulating the ZNF263 and Klotho Expression
by: Wang W, et al.
Published: (2023-04-01) -
Exploring the mechanism of Yishen Daluo decoction in the treatment of multiple sclerosis based on network pharmacology and in vitro experiments
by: Shuo Cheng, et al.
Published: (2023-04-01) -
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
by: Zhang Z, et al.
Published: (2022-07-01)